Recent News

• 03.25.2026 - Lifeward Successfully Closes on Strategic Partnership with Oramed
• 03.18.2026 - Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results
• 03.13.2026 - Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company
• 03.11.2026 - Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement
• 03.10.2026 - Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
• 03.02.2026 - Lifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Personal Exoskeleton
• 02.25.2026 - Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors
• 02.20.2026 - Lifeward Announces Reverse Share Split
• 02.17.2026 - Lifeward’s ReWalk Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers

Recent Filings

• 03.25.2026 - 8-K Current report
• 03.20.2026 - 8-K Current report
• 03.18.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.18.2026 - 8-K Current report
• 03.18.2026 - EX-99.1 EX-99.1
• 03.13.2026 - 8-K Current report
• 03.11.2026 - 8-K Current report
• 03.02.2026 - 8-K Current report
• 02.27.2026 - 8-K Current report
• 02.25.2026 - 8-K Current report